A major international collaboration led by Melbourne researchers has discovered that the world’s most widespread malaria parasite infects humans by hijacking a protein the body cannot live without.
The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
The study, led by the Walter and Eliza Hall Institute’s Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, found that the deadly malaria parasite Plasmodium vivax (P. vivax) causes infection through latching onto the human transferrin receptor protein, which is crucial for iron delivery into the body’s young red blood cells.
Published today in Science, the discovery has solved a mystery that researchers have been grappling with for decades.
Associate Professor Tham, who is also a HHMI-Wellcome International Research Scholar, said the collective efforts of teams from Australia, New Zealand, Singapore, Thailand, United Kingdom, United States, Brazil and Germany had brought the world closer to a potential effective vaccine against P.vivax malaria.
“P. vivax currently inflicts a huge burden on global health. It is the most common malaria parasite in countries outside of Africa, with more than 16 million clinical cases recorded each year.
“The parasite can lie dormant in the liver for months on end without causing any symptoms, which makes it very sneaky and difficult to treat,” Associate Professor Tham said.
“We now know that P. vivax is hijacking the human transferrin receptor which is essential for transporting iron into the body’s young red blood cells.
“Being able to stop P. vivax from latching onto this receptor and infliltrating the blood is a major breakthrough and important step towards malaria elimination,” she said.
Dr Gruszczyk said once the teams understood how the parasite was gaining entry into the cells, they were able to design antibodies to block the mode of access.
“Using the Australian Synchrotron in Melbourne, we generated a 3D map of the parasite protein which is the mechanism P. vivax uses to latch onto the human transferrin receptor and enter the young red blood cells.
“This map provided an unprecedented view of the parasite protein’s shape, which guided the design of antibodies to block P. vivax from gaining entry into the human cells,” Dr Gruszczyk said.
Associate Professor Tham said they were thrilled to see the antibodies successfully block P. vivax invasion using parasites from both Thailand and Brazil. “We are now looking to include collaborative partners in the Pacific, so we can further test the effectiveness of our antibodies,” she said.
Study collaborator Dr Jonathan Abraham from Harvard University said the results of the new study aligned with a growing body of evidence that could be used to target multiple infectious diseases.
“Transferrin receptor is also co-opted by five viruses that cause Ebola-like diseases in South America. These diseases are known as New World haemorrhagic fevers.
“Our increasing understanding of how several pathogens are taking advantage of transferrin receptor, means we are getting closer to disrupting infection for a number of deadly diseases,” Dr Abraham said.
The Latest on: Malaria parasite
Gates backs gene technologies in fight to end malaria
on April 18, 2018 at 3:15 pm
or alter the insects’ ability to carry and pass on the malaria parasite. The technologies can be extremely powerful, but they are also controversial, since such genetically engineered organisms released into the environment could have an unknown and ... […]
Summit Urges Global Response to Malaria Resurgence
on April 18, 2018 at 2:30 pm
"If we do not maintain the commitments that we are making here today, malaria would go back up and kill over a million children a year, because the drugs and the insecticides are evaded by the mosquito and the parasite." Malaria is estimated to cost the ... […]
Unique protein is a vulnerability in the malaria parasite
on April 18, 2018 at 11:37 am
The malaria parasite is highly dependent on a unique protein for infecting new mosquitoes. This protein could be a target for the development of new drugs. Over a thousand people die from malaria every day. The disease is caused by a single-cell parasite ... […]
Smells Like Malaria; Bad Eggs; Mystery NASH Drug
on April 18, 2018 at 9:48 am
Malaria parasites may change the odor of their hosts, and these "distinctive skin smells" may make them more attractive to mosquitoes. (Proceedings of the National Academy of Sciences) Speaking of malaria, a novel mosquito net and mosquito-control ... […]
Study finds malaria parasites prevalent in North American fawns
on April 18, 2018 at 7:04 am
Researchers who analyzed blood samples from 33 farm-raised, white-tailed fawns in Florida report that about 21 percent—7 of 33—were infected by malaria parasites at some point during the first eight months of life. This research was published in ... […]
Gates warns new fight needed against resurgent malaria
on April 18, 2018 at 6:58 am
If we don't maintain the commitments, malaria would go back up and kill over a million children a year, because the drugs and the insecticides always are evaded by the mosquitos and parasites. "Unsurprisingly, I view data as the lifeblood of how we're ... […]
Computer models combat malaria
on April 18, 2018 at 6:50 am
KAUST researchers predict potential drug targets in the malaria parasite’s metabolism that may reveal new treatment options for malaria. The research team includes (L-R): Xin Gao, Takashi Gojobori, Katsuhiko Mineta and Alyaa M. Abdel-Haleem. Credit ... […]
Malaria makes its hosts smell better to draw more mosquitoes, research finds
on April 18, 2018 at 5:01 am
The results might explain how the disease is able to spread so effectively. Malaria, a disease caused by the parasite genus Plasmodium and spread by mosquitoes, could make you more attractive to the insects. Its findings come to flesh out previous ... […]
Africa: Ready to Beat Malaria: Thematic Areas and Case Studies
on April 17, 2018 at 10:27 pm
Last year, Novartis launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite. This work is done with scientific and financial support from MMV (in collaboration ... […]
Africa: Now or Never - Quashing Malaria Before It Roars Back
on April 17, 2018 at 4:51 pm
One of the reasons malaria threatens to return and spread is that the mosquito and the malaria parasite are developing resistance to the interventions used to fight them. "This has been compounded by a plateau in global funding for malaria since 2010 ... […]
via Google News and Bing News